Projects

European scope

American scope

National scope

Regional scope

European scope

6th Framework Programme EuroFlow™: “Flow cytometry for fast and sensitive diagnosis and follow-up of haematological malignancies”.

This project has received funding from the European Union’s Sixth Framework Programme for research, technological development and demonstration under grant agreement no [GA 018708]. (2006-2009).

7th Framework Programme DIMID: “Development of an Innovative Microfluidic Impedance-based Device for multi-parametric cell analysis”.

This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no [GA 286692]. (2011-2013).

7th Framework Programme DIMIDPlus: “Commercialization of an Innovative Microfluidic Impedance-based Device for multi-parametric cell analysis”.

This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no [GA 606100]. (2013-2015).

Return to top

American scope

Project with American Foundation Multiple Myeloma Research Foundation MMRF: “Minimal Residual Disease to Better Characterize Multiple Myeloma Response and Detect Early Relapse”.

MMRF´s funding collaboration. (2011-2013).

Return to top

National scope

Eureka FRET: “Diagnosis and Classification of Malignances with new tools for sensitive and specific detection of fusion proteins at invidual cell level”.

CDTI’s and Technological funding collaboration. (2009-2012).

IgE: “Identification kit of b cell populations producers of immunoglobulin’s IgE, to diagnosis and sorting type I hypersensitivity”.

CDTI’s and Technological funding collaboration. (2012-2014).

Dendron: “Development of bright, novel dendron-reporters for biomarker identification with flow cytometry”. The aim of the project is to develop new fluorochromes and labeling protocols to be included in multicolor panels.

CDTI’s and CRIN Smart Growth Operating Programme FEDER 2014-2020 funding. (2015-2016).

Platform Cell: “Development of a complete platform for blood cell analysis with high sensitivity and specificity” (2015-2018).

The project aims to promote technological development, innovation and high-quality research.

The project has received funding from the Ministry of Economy, Industry and Competitiveness and the European Regional Development Fund.

Automatism: “Automation of pre-analytical, analytical and post-analytical phases in flow cytometry to assist the decision-making process of the cytometry expert”. Ref: TSI-100700-2016-17. (2016-2018),

The project aims to develop new software tools for automating the cytometry analysis process.

The project has received funding from the Ministry of Energy, Tourism and Digital Agenda within the framework of the 2013-2016 National Plan of Scientific Research, Development and Technological Innovation and the European Regional Development Fun.

MIDAS: (Massive Information Data Analysis Software): Development of a software platform for managing, analyzing and representing data from different sources, with application to relevant data for diseases diagnostic. (2016-2019).

The project aims to promote technological development, innovation and high-quality research.

The project has received funding from the Ministry of Economy and Competitiveness and the European Regional Development Fund.

QUASAR: “Development and validation of a hyperspectral system for analysis of solid tissue biopsies”. (2017-2020)

The Project aims to promote technological development, innovation and high-quality research.

The project has received funding from the Ministry of Science, Innovation and Universities and the European Regional Development Fund.

TIMASCAN: “New detecting, diagnosing and monitoring tool of diseases through the content analysis of the lysosomes in the macrophages with high sensitivity and specificity”.

Ministry of Economy and Competitiveness funding collaboration. (2012-2015).

Return to top

Regional scope

PIG-A: “Research and development of a new reagent for identify mutations in the PIG-A gene X chromosome, and serve as a warning signal for disease prevention, minimizing as much as possible health risk”.

ADE Inversiones y Servicios funding collaboration. (2008-2009).

PRIMER Biomedicina: “Personalized medicine for haematological malignancies”.

ADE Inversiones y Servicios funding collaboration. (ERDF: European Regional Development Fund). (2009-2011).

Boosting high-potential international markets

Operations supported: Direct trade missions (USA, Canada, Poland, United Kingdom, France, Germany and Republic of Korea) participation in international fairs (ICCS 2016 in Bonita Springs, Cytométrie 2016 in Montpellier, CYTO 2017 in Boston, ESCCA 2017 in Thessaloniki and ICCS 2017 in Phoenix), development of international marketing material (diptychs, flyers and displays) and trademark application in USA.

  • Objective: “Achieving a more competitive business fabric”.
  • Results: “Increase in the presence and turnover in strategic international markets”.

The Project has been cofounded by the Business Competitiveness Institute of Castilla y León and the European Regional Development Fund (ERDF). (2016-2017).

Promotion of innovation in the technological field

  • Objective: “Facilitate SMEs access to the applicable tax deductions in accordance with the current legislation”.
  • Results: “Deduction in the Corporate Income Tax, for expenditure in research, development and innovation activities”.

The Project has been cofounded by the Business Competitiveness Institute of Castilla y León and the European Regional Development Fund (ERDF). (2017-2018).

Development of fluorochrome – antibody labelling for specific positions of multicolour cytometers.

  • Objective: “Improve competitiveness with the creation of new processes and products”.
  • Results: “Creation of new labelling protocols”.

The Project has been cofounded by the Institute for Business Competitiveness of Castilla y León (ICE) and the European Regional Development Fund (ERDF). (2016-2019).

Return to top